Search Results - "Lozano Ros, Alberto"
-
1
RE‐START: Exploring the effectiveness of anti‐calcitonin gene‐related peptide resumption after discontinuation in migraine
Published in European journal of neurology (01-04-2024)“…Background and purpose According to the latest European guidelines, discontinuation of monoclonal antibodies against calcitonin gene‐related peptide (anti‐CGRP…”
Get full text
Journal Article -
2
Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn's Disease
Published in International journal of molecular sciences (20-01-2020)“…The Th17 immune response plays a key role in autoimmune diseases such as multiple sclerosis (MS) and inflammatory bowel disease (IBD). Expression of…”
Get full text
Journal Article -
3
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study
Published in CNS drugs (01-03-2024)“…Background Alemtuzumab is a high-efficacy treatment approved for relapsing-remitting multiple sclerosis (RRMS). Although clinical trials and observational…”
Get full text
Journal Article -
4
The profile of refractory chronic cluster headache
Published in Neurological sciences (24-07-2024)“…Chronic cluster headache (CCH) is a relatively rare primary headache disorder whose management is often challenging. The prevalence of refractory CCH (rCCH) is…”
Get full text
Journal Article -
5
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
Published in European journal of neurology (01-05-2024)“…Anti-calcitonin gene-related peptide (CGRP) therapies are recent preventive therapies approved for both episodic and chronic migraine. One of the measures of…”
Get full text
Journal Article -
6
Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis
Published in International journal of molecular sciences (01-10-2023)“…Vitamin D is an environmental factor related to multiple sclerosis that plays a significant role in immune regulation. TGF-β is a superfamily of cytokines with…”
Get full text
Journal Article -
7
Short‐chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study
Published in European journal of neurology (01-03-2022)“…Background and purpose Short‐chain fatty acids (SCFAs) can have pro‐ or anti‐inflammatory properties, but their relationship with multiple sclerosis (MS)…”
Get full text
Journal Article -
8
Evolution of antibody titres against Epstein–Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients
Published in Scientific reports (19-04-2021)“…Epstein–Barr virus (EBV), human herpesvirus 6A/B (HHV-6A/B) and multiple sclerosis (MS)-associated retrovirus (MSRV) have been described as possible MS…”
Get full text
Journal Article -
9
Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response
Published in Neurological sciences (01-09-2020)“…Background Plasma exchange (PLEX) is a therapeutic option in the treatment of acute attacks of Demyelinating Diseases of the Central Nervous System (DDCNS)…”
Get full text
Journal Article -
10
Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse
Published in Multiple sclerosis and related disorders (01-11-2017)“…Fibrinogen is a protein that plays a key role in blood coagulation and thrombosis and it is involved in several inflammatory processes; in multiple sclerosis…”
Get full text
Journal Article -
11
Hepatotoxicity after high‐dose intravenous methylprednisolone in multiple sclerosis patients
Published in Clinical case reports (01-08-2017)“…Key Clinical Message Hepatotoxicity is a rare adverse event of methylprednisolone that should be considered in clinical practice. In patients at risk, we…”
Get full text
Journal Article -
12
-
13
Clinical predictors of therapeutic failure of occipital nerve stimulation in refractory chronic cluster headache
Published in Cephalalgia (01-05-2024)“…Occipital nerve stimulation (ONS) is a treatment with evidence in refractory chronic cluster headache (CCH). However, the variable response rate and cost make…”
Get more information
Journal Article -
14
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Published in Journal of neurology, neurosurgery and psychiatry (22-05-2024)“…BackgroundAnti-CGRP monoclonal antibodies (anti-CGRP MAbs) are approved and available treatments for migraine prevention. Patients do not respond alike and…”
Get full text
Journal Article -
15
Cytokine profile during pregnancy predicts relapses during pregnancy and postpartum in multiple sclerosis
Published in Journal of the neurological sciences (15-07-2020)“…To explore the serum cytokine profile associated with disease activity during pregnancy and postpartum in MS, and to assess any potential biomarkers predicting…”
Get full text
Journal Article -
16
Pregnancy exposure to disease-modifying drugs in multiple sclerosis: a prospective study
Published in Medicina clinica (27-03-2020)“…In multiple sclerosis (MS), foetal exposure to disease-modifying drugs (DMDs) carries varying degrees of risk. We sought to analyse the clinical and obstetric…”
Get more information
Journal Article -
17
Neurofilament Light Chain Levels In Pregnant Multiple Sclerosis Patients (P4.2-092)
Published in Neurology (09-04-2019)“…Abstract only…”
Get full text
Journal Article -
18
Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study
Published in CNS drugs (01-12-2020)“…Background Dimethyl fumarate (DMF) has demonstrated efficacy in phase III studies. However, real-world data are still limited. Objective The objective of this…”
Get full text
Journal Article -
19
Pregnancy exposure to disease-modifying drugs in multiple sclerosis: a prospective study
Published in Medicina clínica (English ed.) (27-03-2020)“…In multiple sclerosis (MS), fetal exposure to DME carries varying degrees of risk. We aim to analyze the clinical and obstetric outcomes of MS patients (MSp)…”
Get full text
Journal Article -
20
Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report
Published in Revista de neurologiá (16-05-2022)“…Relapsing-remitting multiple sclerosis (RRMS) treatment has significantly changed in recent years because of the discovery of new molecules that have shown…”
Get full text
Journal Article